INTERPACE BIOSCIENCES, INC. (IDXG) › Shareholders' EquityINTERPACE BIOSCIENCES, INC. (IDXG) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $69.51M2011: $59.52M2012: $35.63M2013: $32.48M2014: $19.43M2015: $10.07M2016: -$10.11M2017: $22.89M2018: $15.45M2019: -$4.48M2020: -$29.08M2021: -$42.42M2022: -$58.09M2023: -$55.54M2024: -$2.22M2025: $22.36M$22.36M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$22.36M+1108.7%2024-$2.22M+96.0%2023-$55.54M+4.4%2022-$58.09M-36.9%2021-$42.42M-45.9%2020-$29.08M-549.3%2019-$4.48M-129.0%2018$15.45M-32.5%2017$22.89M+326.4%2016-$10.11M-200.4%2015$10.07M-48.2%2014$19.43M-40.2%2013$32.48M-8.8%2012$35.63M-40.1%2011$59.52M-14.4%2010$69.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share